search
Back to results

Reducing Pain and Promoting Neurodevelopment Among Preterm Neonates

Primary Purpose

Neonatal Disease, Neonatal Disorder

Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Multisensory stimulation with soft tissue therapy
Routine hospital care
Sponsored by
Asir John Samuel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neonatal Disease focused on measuring Neonates, Pain

Eligibility Criteria

24 Hours - 5 Days (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria

  • Preterm between 30- 36 weeks of gestation
  • Birth weight >1000 g
  • Not receiving analgesics/sedatives
  • APGAR score ranged between 4-6 in 1 min. & 7 to 9 in 5 min.
  • Undergoing routine healthcare procedures in NICU

Exclusion Criteria

  • Preterm with surgery
  • Preterm having unstable vitals
  • Preterm with congenital malformations
  • Preterm who require mechanical ventilation
  • Having inborn errors of metabolism and also with seizures disorders,

Sites / Locations

  • Neonatal Intensive Care Unit, Maharishi Markandeshwar Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Group A

Group B

Arm Description

Multisensory stimulation and soft tissue therapy

Routine Hospital care

Outcomes

Primary Outcome Measures

The Premature infant pain profile-Revised (PIPP-R)
Measuring procedural pain among neonates, having 1 to 3 scoring. 0 describe normal and 3 describes low score
Neonatal pain agitation sedation scale (N-PASS)
Measuring procedural pain along with sedation, having score ranged from 0 to 2, 0 describes normal and 2 describes low score

Secondary Outcome Measures

Infant neurological international battery (INFANIB)
Measuring neurodevelopmental outcomes among preterm neonates. Scoring is from 5, 3, and 1. Score 5 means Normal, score 3 means mildly abnormal, score 1 means markedly abnormal. Total score for preterm neonate is 70.
Premie-Neuro
Premie-neuro used for measuring neurodevelopmental outcome in preterm neonates between 23 and 37 weeks of gestation. It has total 24 items. Each item has a score of 1,3, and 5. Total score is 120. Score less than 70 is considered as abnormal, score between 70-99 is questionable, and score above 100 is normal.

Full Information

First Posted
April 25, 2020
Last Updated
October 20, 2023
Sponsor
Asir John Samuel
Collaborators
Department of Science and Technology, Government of India, Maharishi Markendeswar University (Deemed to be University)
search

1. Study Identification

Unique Protocol Identification Number
NCT04366102
Brief Title
Reducing Pain and Promoting Neurodevelopment Among Preterm Neonates
Official Title
Multisensory Stimulation and Soft Tissue Therapy on Procedural Pain and Neurodevelopment Among Preterm Neonates
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
October 22, 2020 (Actual)
Primary Completion Date
September 16, 2023 (Actual)
Study Completion Date
October 20, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Asir John Samuel
Collaborators
Department of Science and Technology, Government of India, Maharishi Markendeswar University (Deemed to be University)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To determine the effects of multisensory stimulation and soft tissue therapy on procedural pain and neurodevelopment among neonates admitted to the NICU is the aim of the study. The study will be two groups randomized clinical trial of five days intervention program. The intervention will be given among two groups. Group A will receive both multisensory stimulation and soft tissue therapy, Group B will receive only regular hospital care. The PIPP and N-PASS will be used for assessing pain. The INFANIB and Premie-Neuro will be used for assessing neuromotor development among neonates. The outcomes will be taken before and after the fifth day of the intervention. Multisensory stimulation and soft tissue therapy might help in reducing pain and promoting neurodevelopment.
Detailed Description
This study will utilize two parallel groups, randomised design to analyze the effects of soft tissue therapy and multisensory stimulation on pain and neurodevelopment. 104 neonates admitted in NICU will be recruited through purposive sampling for the trial. Procedural pain will be assessed with PIPP and N-PASS through recorded video. Neurodevelopmental outcomes will be assessed with INFANIB Scale and Premie-Neuro. The measurements will be taken after 24 hours of birth at the baseline and after the fifth day of the intervention. The treatment will be given into two groups i.e. Group A (Multisensory stimulation and soft tissue therapy group), Group B (routine hospital care). MSS will consist of Auditory Stimulation, Tacto-Kinesthetic stimulation, Vestibular stimulation, Visual stimulation, Oral-stimulation, and Olfactive stimulation. Soft tissue therapy consisted of stroking, effleurage, skin rolling, and kneading techniques, Will be given in 5 Phases-Forehead and face, Back and Neck, Chest and abdomen, upper-lower limbs. Total 30 min. of the treatment plan, per day, will be given to the neonates, after 30 min. of feed, for up to 5 days of NICU stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Disease, Neonatal Disorder
Keywords
Neonates, Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Neonates admitted in the Neonatal intensive care unit will be divided randomly into 2 groups.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
68 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A
Arm Type
Experimental
Arm Description
Multisensory stimulation and soft tissue therapy
Arm Title
Group B
Arm Type
Experimental
Arm Description
Routine Hospital care
Intervention Type
Other
Intervention Name(s)
Multisensory stimulation with soft tissue therapy
Intervention Description
Multisensory stimulation with soft tissue therapy will be given. Multisensory stimulation consists of Auditory, vestibular, tactile, olfactive, oromotor, Visual, and Kinesthetic stimulation. Soft tissue therapy consists of stroking, effleurage, fingertip kneading, tapping, and skin rolling will be given. Total intervention will be given for 30 min. 5 times per week
Intervention Type
Other
Intervention Name(s)
Routine hospital care
Intervention Description
Routine hospital care will be given to the preterm neonates
Primary Outcome Measure Information:
Title
The Premature infant pain profile-Revised (PIPP-R)
Description
Measuring procedural pain among neonates, having 1 to 3 scoring. 0 describe normal and 3 describes low score
Time Frame
Change score of PIPP at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention
Title
Neonatal pain agitation sedation scale (N-PASS)
Description
Measuring procedural pain along with sedation, having score ranged from 0 to 2, 0 describes normal and 2 describes low score
Time Frame
Change score of N-PASS at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention
Secondary Outcome Measure Information:
Title
Infant neurological international battery (INFANIB)
Description
Measuring neurodevelopmental outcomes among preterm neonates. Scoring is from 5, 3, and 1. Score 5 means Normal, score 3 means mildly abnormal, score 1 means markedly abnormal. Total score for preterm neonate is 70.
Time Frame
Change score of INFANIB at the baseline and after five days of intervention
Title
Premie-Neuro
Description
Premie-neuro used for measuring neurodevelopmental outcome in preterm neonates between 23 and 37 weeks of gestation. It has total 24 items. Each item has a score of 1,3, and 5. Total score is 120. Score less than 70 is considered as abnormal, score between 70-99 is questionable, and score above 100 is normal.
Time Frame
Change score of Premie-Neuro at the baseline and after five days of intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
24 Hours
Maximum Age & Unit of Time
5 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria Preterm between 30- 36 weeks of gestation Birth weight >1000 g Not receiving analgesics/sedatives APGAR score ranged between 4-6 in 1 min. & 7 to 9 in 5 min. Undergoing routine healthcare procedures in NICU Exclusion Criteria Preterm with surgery Preterm having unstable vitals Preterm with congenital malformations Preterm who require mechanical ventilation Having inborn errors of metabolism and also with seizures disorders,
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Neha Sharma, MPT
Organizational Affiliation
Maharishi Markandeshwar institute of Physiotherapy and Rehabilitation
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Asir J Samuel, MPT, PhD
Organizational Affiliation
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Kusum Mahajan, MD
Organizational Affiliation
Maharishi Markandeshwar Institute of Medical Sciences & Research
Official's Role
Study Chair
Facility Information:
Facility Name
Neonatal Intensive Care Unit, Maharishi Markandeshwar Hospital
City
Ambala
State/Province
Haryana
ZIP/Postal Code
133207
Country
India

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data (IPD) will be shared via Mendeley Dataset
IPD Sharing Time Frame
Study Protocol - December, 2020 Statistical Analysis Plan (SAP) - December, 2020 Informed Consent Form (ICF) - December, 2020
IPD Sharing Access Criteria
By publishing study protocol with detailed statistical Analysis Plan in SCOPUS and PubMed indexed journals
Citations:
PubMed Identifier
30026767
Citation
Zeraati H, Nasimi F, Rezaeian A, Shahinfar J, Ghorban Zade M. Effect of Multi-sensory Stimulation on Neuromuscular Development of Premature Infants: A Randomized Clinical Trial. Iran J Child Neurol. 2018 Summer;12(3):32-39.
Results Reference
background
PubMed Identifier
25511005
Citation
de Melo GM, Lelis AL, de Moura AF, Cardoso MV, da Silva VM. [Pain assessment scales in newborns: integrative review]. Rev Paul Pediatr. 2014 Dec;32(4):395-402. doi: 10.1016/j.rpped.2014.04.007.
Results Reference
background
PubMed Identifier
35385466
Citation
Sharma N, Samuel AJ. Multisensory Stimulation and Soft Tissue Therapy on Pain and Neurodevelopment Among Preterm Neonates. Pediatr Phys Ther. 2022 Apr 1;34(2):277-282. doi: 10.1097/PEP.0000000000000887.
Results Reference
derived
Links:
URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045934/
Description
Effect of Multi-sensory Stimulation on Neuromuscular Development of Premature Infants: A Randomized Clinical Trial
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311795/
Description
Pain assessment scales in newborns: integrative review

Learn more about this trial

Reducing Pain and Promoting Neurodevelopment Among Preterm Neonates

We'll reach out to this number within 24 hrs